The US Food and Drug Administration (FDA) recently gave the green light to the drug Leqembi, which slows the rate of progression of Alzheimer’s disease. This medicine became the first new drug against this insidious disease to be admitted to the American market in the last two decades.
Active ingredient: lecanemab
Prescription medicine
Storage temperature 2-8 degrees
